Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJETI.L Regulatory News (JETI)

  • There is currently no data for JETI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Shares

11 Mar 2020 16:58

RNS Number : 8363F
JPMorgan European Invest Tst PLC
11 March 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN EUROPEAN INVESTMENT TRUST PLC

CONVERSION OF SHARES

 

Legal Entity Identifier: 549300D8SPJFHBDGXS57

Information disclosed in accordance with LR 9.6.4 (6)

The Board of JPMorgan European Investment Trust plc (the 'Company') announces that valid Conversion Notices have been received in respect of the following Shares (the 'Converting Shares'):

 

- 1,003,249 Growth Shares; and

- 12,664,930 Income Shares.

 

At 8.00 a.m. on 16th March 2020, the above Converting Shares will be converted into:

- 6,518,323 Growth Shares; and

- 1,919,923 Income Shares.

 

(the 'Resulting Shares')

 

Following the conversion, the total number of Shares in issue at 8.00 a.m. on 16th March 2020 will be:

- 74,259,820 Growth Shares; and

- 89,181,557 Income Shares.

 

The conversion calculations were based on the relative net asset values of the two share classes (net of accrued management expenses and applicable costs of conversion) as at close of business on 4th March 2020.

 

The resulting Conversion Ratios were:

- for every Converting Share which is a Growth Share, holders are entitled to 1.913705 Income Shares; and

- for every Converting Share which is an Income Share, holders are entitled to 0.514675 Growth Shares.

 

Individual Shareholders' entitlements on conversion will be rounded down to the nearest whole number of Shares. The Resulting Shares will rank pari passu with the existing Shares of the relevant class of Resulting Share. The Nominal Value of the shares following the conversion will be Growth Shares 3.90508 pence and Income Shares 2.04059 pence.

 

The Resulting Shares have been allotted subject only to admission to the Official List and to trading on the London Stock Exchange's main market for listed securities ('Admission'). The relevant applications have been made and Admission is expected to occur at 8.00 a.m. on 16th March 2020. Dealings in such shares are expected to commence at 8.00 a.m. on 16th March 2020. It is anticipated that Certificates in respect of the Resulting Shares will be posted by 26th March 2020.

 

Terms used in this announcement shall, unless the context otherwise requires, bear the meaning given to them in the Company's articles of association.

 

11th March 2020

For and on behalf of

JPMorgan Funds Limited, Secretary

For further information, please contact: Paul Winship Tel. 020 7742 9815

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCJBMFTMTABBIM
Date   Source Headline
21st Jul 202011:26 amRNSNet Asset Value(s)
20th Jul 202011:20 amRNSGearing Announcement
20th Jul 202010:50 amRNSNet Asset Value(s)
17th Jul 202011:14 amRNSNet Asset Value(s)
16th Jul 202011:10 amRNSNet Asset Value(s)
15th Jul 20205:08 pmRNSHolding(s) in Company
15th Jul 20204:35 pmRNSResult of AGM
15th Jul 202011:35 amRNSNet Asset Value(s)
14th Jul 20205:41 pmRNSHolding(s) in Company
14th Jul 202010:45 amRNSNet Asset Value(s)
13th Jul 20204:20 pmRNSTen Largest Investments
13th Jul 202011:35 amRNSGearing Announcement
13th Jul 202011:16 amRNSNet Asset Value(s)
10th Jul 202011:27 amRNSNet Asset Value(s)
9th Jul 202010:35 amRNSNet Asset Value(s)
8th Jul 202010:44 amRNSNet Asset Value(s)
7th Jul 202010:44 amRNSNet Asset Value(s)
6th Jul 202011:05 amRNSGearing Announcement
6th Jul 202011:02 amRNSNet Asset Value(s)
3rd Jul 202010:41 amRNSNet Asset Value(s)
2nd Jul 202010:39 amRNSNet Asset Value(s)
1st Jul 202012:16 pmRNSNet Asset Value(s)
30th Jun 20206:00 pmRNSTotal Voting Rights
30th Jun 202010:55 amRNSNet Asset Value(s)
29th Jun 202011:42 amRNSGearing Announcement
29th Jun 202011:25 amRNSNet Asset Value(s)
26th Jun 202011:14 amRNSNet Asset Value(s)
25th Jun 202011:06 amRNSNet Asset Value(s)
24th Jun 202011:40 amRNSNet Asset Value(s)
23rd Jun 20204:33 pmRNSHolding(s) in Company
23rd Jun 202011:42 amRNSNet Asset Value(s)
22nd Jun 202011:25 amRNSGearing Announcement
22nd Jun 202010:56 amRNSNet Asset Value(s)
19th Jun 202011:18 amRNSNet Asset Value(s)
18th Jun 202010:58 amRNSNet Asset Value(s)
17th Jun 202011:20 amRNSNet Asset Value(s)
16th Jun 202011:04 amRNSNet Asset Value(s)
15th Jun 20202:02 pmRNSGearing Announcement
15th Jun 202011:27 amRNSNet Asset Value(s)
15th Jun 20208:40 amRNSDividend Declaration
15th Jun 20207:27 amRNSFinal Results
12th Jun 202010:49 amRNSNet Asset Value(s)
11th Jun 202010:46 amRNSNet Asset Value(s)
10th Jun 20202:59 pmRNSTen Largest Investments
10th Jun 202010:50 amRNSNet Asset Value(s)
9th Jun 202010:43 amRNSNet Asset Value(s)
8th Jun 202012:30 pmRNSGearing Announcement
8th Jun 202011:49 amRNSNet Asset Value(s)
5th Jun 202011:08 amRNSNet Asset Value(s)
4th Jun 202010:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.